2187 résultats correspondant à votre recherche

  • Neuroinflammatory disorders and mastocytosis: A possible association?

    Olivier Hermine

    Source :

    J Allergy Clin Immunol Pract

    Pmid / DOI:

    31077881

  • Lessons to Learn From Low-Dose Cyclosporin-A: A New Approach for Unexpected Clinical Applications.

    Olivier Hermine

    Source :

    Front Immunol

    2019 jan 1

    Pmid / DOI:

    30984176

  • Omalizumab Therapy for Mast Cell-Mediator Symptoms in Patients with ISM, CM, MMAS, and MCAS.

    Laurent Frenzel, Olivier Hermine

    Source :

    J Allergy Clin Immunol Pract

    Pmid / DOI:

    30954641

  • Transmettre

    Programme doctorants internationaux

  • Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.

    Jérome Hadjadj, Laura BARNABEI, Alain Fischer, Frédéric Rieux-Laucat

    Source :

    Science

    2020 juil 13

    Pmid / DOI:

    32661059

  • Copa Syndrome: a Novel Autosomal Dominant Immune Dysregulatory Disease.

    Source :

    J. Clin. Immunol.

    2016 mai 1

    Pmid / DOI:

    27048656

  • Mutations in COPA lead to abnormal trafficking of STING to the Golgi and interferon signaling.

    Alice Lepelley, Bénédicte Neven, Luís Seabra, Marie-Louise Frémond, Yanick Crow

    Source :

    The journal of experimental medicine 2020

    2020 nov 2

    Pmid / DOI:

    32725128

  • Marie-Louise Fremond et Alice Lepelley

    Accélérer la recherche

    Le syndrome COPA : une nouvelle interféronopathie

  • Documents

    Annual report 2019

    • pdf
    • 6.81 Mo
  • The deployment of cell lineages that form the mammalian heart.

    Source :

    Nat Rev Cardiol

    2018 nov 1

    Pmid / DOI:

    30266935

  • The deployment of cell lineages that form the mammalian heart.

    Source :

    Nat Rev Cardiol

    2018 nov 1

    Pmid / DOI:

    30266935